Rhythm Pharmaceuticals (NASDAQ:RYTM) is gearing up to announce its quarterly earnings on Tuesday, 2025-11-04. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Rhythm Pharmaceuticals will report an earnings per share (EPS) of $-0.72.
Anticipation surrounds Rhythm Pharmaceuticals's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Earnings History Snapshot
During the last quarter, the company reported an EPS missed by $0.08, leading to a 1.63% increase in the share price on the subsequent day.
Here's a look at Rhythm Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.67 | -0.68 | -0.73 | -0.80 |
| EPS Actual | -0.75 | -0.81 | -0.72 | -0.73 |
| Price Change % | 2.00 | -6.00 | -1.00 | 11.00 |
Market Performance of Rhythm Pharmaceuticals's Stock
Shares of Rhythm Pharmaceuticals were trading at $113.76 as of October 31. Over the last 52-week period, shares are up 101.49%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Rhythm Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
